Cargando…
Impact of COVID-19 Pandemic on Respiratory Syncytial Virus (RSV) Prophylaxis Program: A Tertiary-Care Center Experience
Objectives: The purpose of this investigation was to evaluate the effects of the COVID-19 pandemic on the respiratory syncytial virus (RSV) prevention program at our institution across three time frames: 2019-2020, 2020-2021, and 2021-2022. Methods: We carried out a descriptive, single-site observat...
Autores principales: | Kelabi, Hamza M, Alharbi, Adel S, Alshamrani, Abdullah S, Baqais, Khaled, Alenazi, Ayed M, Alqwaiee, Mansour M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460243/ https://www.ncbi.nlm.nih.gov/pubmed/37637610 http://dx.doi.org/10.7759/cureus.42563 |
Ejemplares similares
-
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2023) -
Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015) -
Management of asthma exacerbation in the emergency departments
por: Al-Shamrani, Abdullah, et al.
Publicado: (2019) -
Wheezing in children: Approaches to diagnosis and management
por: Al-Shamrani, Abdullah, et al.
Publicado: (2019) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)